Schloss P, Mayser W, Betz H
Abteilung Neurochemie, Max-Planck-Institut für Hirnforschung, Frankfurt/M. Germany.
FEBS Lett. 1992 Jul 27;307(1):76-80. doi: 10.1016/0014-5793(92)80905-v.
The re-uptake of neurotransmitters into the nerve terminal terminates synaptic transmission at most central synapses and constitutes a key step in the modulation of synaptic efficacy. Recently, the cloning of several Na(+)-driven neurotransmitter transporters has resulted in the description of a novel family of homologous membrane proteins, each with 12 transmembrane segments. These transporters constitute major targets of widely used drugs, and modulation of transporter gene expression and/or activity may represent an important substrate for plasticity in the nervous system.
神经递质重新摄取到神经末梢可终止大多数中枢突触的突触传递,并构成调节突触效能的关键步骤。最近,几种钠驱动的神经递质转运体的克隆导致了一个新的同源膜蛋白家族的描述,每个家族都有12个跨膜片段。这些转运体构成了广泛使用药物的主要靶点,转运体基因表达和/或活性的调节可能代表神经系统可塑性的重要基础。